EUVIMEDEUVIMED entdecken
Open Access

Serotonergic dysfunction impairs locomotor coordination in spinal muscular atrophy

Nicolas Delestrée, Evangelia Semizoglou iD, John G Pagiazitis, Aleksandra Vukojicic, Estelle Drobac, Vasilissa Paushkin, George Z Mentis

Brain · 02.11.2023 · 146 (11) · 4574-4593

DOI: 10.1093/brain/awad221 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 07.09.2023. Verfasst von Nicolas Delestrée und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032, USA. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Muscular Atrophy, Spinal. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAAA NIH HHS, NINDS NIH HHS, NINDS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuromodulation by serotonin regulates the activity of neuronal networks responsible for a wide variety of essential behaviours. Serotonin (or 5-HT) typically activates metabotropic G protein-coupled receptors, which in turn initiate second messenger signalling cascades and induce short and long-lasting behavioural effects. Serotonin is intricately involved in the production of locomotor activity and gait control for different motor behaviours. Although dysfunction of serotonergic neurotransmission has been associated with mood disorders and spasticity after spinal cord injury, whether and to what extent such dysregulation is implicated in movement disorders has not been firmly established. Here, we investigated whether serotonergic neuromodulation is affected in spinal muscular atrophy (SMA), a neurodegenerative disease caused by ubiquitous deficiency of the SMN protein. The hallmarks of SMA are death of spinal motor neurons, muscle atrophy and impaired motor control, both in human patients and mouse models of disease. We used a severe mouse model of SMA, that closely recapitulates the severe symptoms exhibited by type I SMA patients, the most common and most severe form of the disease. Together, with mouse genetics, optogenetics, physiology, morphology and behavioural analysis, we report severe dysfunction of serotonergic neurotransmission in the spinal cord of SMA mice, both at early and late stages of the disease. This dysfunction is followed by reduction of 5-HT synapses on vulnerable motor neurons. We demonstrate that motor neurons innervating axial and trunk musculature are preferentially affected, suggesting a possible cause for the proximo-distal progression of disease, and raising the possibility that it may underlie scoliosis in SMA patients. We also demonstrate that the 5-HT dysfunction is caused by SMN deficiency in serotonergic neurons in the raphe nuclei of the brainstem. The behavioural significance of the dysfunction in serotonergic neuromodulation is underlined by inter-limb discoordination in SMA mice, which is ameliorated when selective restoration of SMN in 5-HT neurons is achieved by genetic means. Our study uncovers an unexpected dysfunction of serotonergic neuromodulation in SMA and indicates that, if normal function is to be restored under disease conditions, 5-HT neuromodulation should be a key target for therapeutic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesMuscular Atrophy, SpinalHumansMiceAnimalsSerotoninMotor NeuronsSpinal CordDisease Models, Animal

Stichwörter der Autor:innen

SMAlocomotionmotor neuron diseaseserotoninsynapse

Substanzen

Serotonin

Autor:innen und Institutionen

  • Center for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032, USA.
  • Department of Neurology, Columbia University, New York, NY 10032, USA.
  • Department of Pathology and Cell Biology, Columbia University, New York, NY 10032, USA.

ORCID-Profile: Evangelia Semizoglou

Förderung

  • NIAAA NIH HHS
  • NINDS NIH HHS
  • NINDS
  • NIH
  • Neuroscience Research
  • SMA Foundation
  • AFM Téléthon

Zitieren

APA

Delestrée, N., Semizoglou, E., Pagiazitis, J. G., Vukojicic, A., Drobac, E., Paushkin, V., & Mentis, G. Z. (2023). Serotonergic dysfunction impairs locomotor coordination in spinal muscular atrophy. Brain, 146(11), 4574-4593. https://doi.org/10.1093/brain/awad221

Vancouver

Delestrée N, Semizoglou E, Pagiazitis JG, Vukojicic A, Drobac E, Paushkin V, et al. Serotonergic dysfunction impairs locomotor coordination in spinal muscular atrophy. Brain. 2023;146(11):4574-4593. doi:10.1093/brain/awad221

BibTeX
@article{Delestre2023,
  author = {Delestrée, Nicolas and Semizoglou, Evangelia and Pagiazitis, John G and Vukojicic, Aleksandra and Drobac, Estelle and Paushkin, Vasilissa and Mentis, George Z},
  title = {Serotonergic dysfunction impairs locomotor coordination in spinal muscular atrophy},
  journal = {Brain},
  year = {2023},
  volume = {146},
  number = {11},
  pages = {4574--4593},
  doi = {10.1093/brain/awad221}
}
Kostenlos starten →